Skip to main content

Seaport Therapeutics

Boston, United States

Seaport Therapeutics is a clinical-stage biopharmaceutical company that develops neuropsychiatric medicines.

$15.0M raised
Mar 2026
Grant

Founder Contacts

30,000+ verified contacts
Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Seaport Therapeutics

How much funding has Seaport Therapeutics raised?
Seaport Therapeutics has raised $15.0M in total funding. The most recent round was Grant. The last funding was announced in March 2026.
Who are Seaport Therapeutics's investors?
Seaport Therapeutics's investors include General Atlantic, ARCH Venture Partners, Foresite Capital, Advanced Research Projects Agency for Health, T. Rowe Price.
Where is Seaport Therapeutics headquartered?
Seaport Therapeutics is headquartered in Boston, United States.
What does Seaport Therapeutics do?
Seaport Therapeutics is a clinical-stage biopharmaceutical company that develops neuropsychiatric medicines.
What stage is Seaport Therapeutics at?
Seaport Therapeutics is at the Grant stage.
Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .

MLA
"Seaport Therapeutics — Funding & Investors." VCBacked, March 3, 2026, https://www.vcbacked.co/company/seaport-therapeutics. Accessed July 4, 2026.
APA
VCBacked. (2026). Seaport Therapeutics — Funding & Investors. Retrieved July 4, 2026, from https://www.vcbacked.co/company/seaport-therapeutics
Wikipedia (cite web)
{{cite web |title=Seaport Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/seaport-therapeutics |website=VCBacked |access-date=July 4, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated .